Shao ZM - Search Results

1

Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.

Shi TY, Jiang Z, Jiang R, Yin S, Wang MY, Yu KD, Shao ZM, Sun MH, Zang R, Wei Q. Shi TY, et al. Among authors: shao zm. Tumour Biol. 2015 Sep;36(9):6919-27. doi: 10.1007/s13277-015-3394-2. Epub 2015 Apr 9. Tumour Biol. 2015. PMID: 25854172

2

The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, Shao ZM. Song CG, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2006 Oct;132(10):617-26. doi: 10.1007/s00432-006-0105-9. Epub 2006 Jul 12. J Cancer Res Clin Oncol. 2006. PMID: 16835750

3

Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast. 2007 Jun;16(3):307-15. doi: 10.1016/j.breast.2006.12.011. Epub 2007 Feb 12. Breast. 2007. PMID: 17293115

4

A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.

Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, Shao ZM. Hu Z, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2007 Dec;133(12):969-78. doi: 10.1007/s00432-007-0244-7. Epub 2007 Jun 12. J Cancer Res Clin Oncol. 2007. PMID: 17562079

5

Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients.

Rao NY, Hu Z, Li WF, Huang J, Ma ZL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM. Rao NY, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Feb;113(3):467-77. doi: 10.1007/s10549-008-9965-9. Epub 2008 Mar 16. Breast Cancer Res Treat. 2009. PMID: 18343994

6

Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.

Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Fan L, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Sep;117(2):409-16. doi: 10.1007/s10549-008-0303-z. Epub 2009 Jan 20. Breast Cancer Res Treat. 2009. PMID: 19153831

7

A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.

Yu KD, Di GH, Fan L, Wu J, Hu Z, Shen ZZ, Huang W, Shao ZM. Yu KD, et al. Among authors: shao zm. FASEB J. 2009 Jul;23(7):2274-87. doi: 10.1096/fj.08-124073. Epub 2009 Feb 19. FASEB J. 2009. PMID: 19228880

8

Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.

Yu KD, Di GH, Fan L, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast Cancer Res Treat. 2009 Oct;117(3):675-7. doi: 10.1007/s10549-009-0353-x. Epub 2009 Feb 26. Breast Cancer Res Treat. 2009. PMID: 19242790 No abstract available.

9

Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM. Yu KD, et al. Among authors: shao zm. Hum Mol Genet. 2009 Jul 1;18(13):2502-17. doi: 10.1093/hmg/ddp171. Epub 2009 Apr 7. Hum Mol Genet. 2009. PMID: 19351655

10

Concurrent hormone and radiation therapy in patients with breast cancer: how does chemotherapy affect treatment?

Yu KD, Shao ZM. Yu KD, et al. Among authors: shao zm. Lancet Oncol. 2009 May;10(5):442-4; author reply 445-6. doi: 10.1016/S1470-2045(09)70090-7. Lancet Oncol. 2009. PMID: 19410191 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters